As far as I know they have an epilepsy trial but not to do with this product. It's to see the effectiveness of cannabis when used on epileptic patients as far as I'm aware / at least that's my understanding. To be honest, this product isn't special nor is it patented. Another larger pharmaceutical company can always come in and create their own cannepil if they wanted and have a larger marketing team plus brand awareness behind them.
Also a big issue for me is the ridiculous directors salaries.
Ann: Trading Halt, page-33
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.065(39.4%) |
Mkt cap ! $11.13M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 23.0¢ | 17.5¢ | $97.37K | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 6921 | 5 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |